Fulcrum Therapeutics, Inc. (FULC): A Bull Case Theory

We came across a bullish thesis on Fulcrum Therapeutics, Inc. (FULC) on Stock Pursuit’s Substack. In this article, we will summarize the bulls’ thesis on FULC. Fulcrum Therapeutics, Inc. (FULC)'s share was trading at $6.44 as of 23^rd May. FULC’s trailing P/E was 312.50 according to Yahoo Finance.

[caption id="attachment_1238816" align="aligncenter" width="768"] A scientist in a lab conducting research on cell-based therapeutics and biotechnology.[/caption]

Fulcrum Therapeutics (FULC) recently surged over 110% from around $3.30 to $7.00, reflecting growing optimism but also...